Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin B3 may help prevent hair loss and promote hair growth by protecting scalp cells from stress and reducing hair growth-blocking proteins.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

DDS treatment for LABD can cause severe side effects like anemia and hair loss, requiring careful monitoring.

Proguanil can cause anemia and hair loss in kidney disease patients.

Ixekizumab has known and some unexpected side effects.

Finasteride and GIZh-72 reduce inflammation, with GIZh-72 being more effective.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

The document concludes that Syndromes of Severe Insulin Resistance are rare disorders with limited treatment options.

DHA-NLC may improve drug delivery and reduce side effects for cancer treatment.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

A woman with lupus and severe nerve damage improved with specific treatments.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

Drugs that block GSK-3 show promise for treating various diseases.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

DDR-II hair follicle cells don't respond to 1, 25-dihydroxyvitamin D3, aiding diagnosis.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Cyclosporin A and FK506 can start new hair growth without needing immunosuppression.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Metformin reduces insulin resistance in PCOS, but combining it with finasteride offers extra benefits.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.